Compounds > lissamine rhodamine b
Page last updated: 2024-08-24

lissamine rhodamine b and Colonic Neoplasms

lissamine rhodamine b has been researched along with Colonic Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marko, D; Schroeter, A1
Ekblad, L; Johnsson, A; Kjellén, E; Mineta, H; Wennerberg, J; Yamatodani, T1
Baay, MF; de Pooter, CM; Korst, AE; Lambrechts, HA; Lardon, F; Pattyn, GG; Pauwels, B; Vermorken, JB1
Apan, TR; Chávez, IO; Martínez-Vázquez, M1
Faessel, HM; Greco, WR; Levasseur, LM; Slocum, HK1
Aronne, T; Caliò, E; Franchi, F; Gargano, L; Pagani Guazzugli Bonaiuti, V; Sbaffi, E; Seminara, P1
Giaccone, G; Lyaruu, DM; Peters, GJ; Pinedo, HM; Pizao, PE; van Ark-Otte, J; Winograd, B1
Bokesch, H; Boyd, MR; Kenney, S; McMahon, J; Monks, A; Scudiero, D; Skehan, P; Storeng, R; Vistica, D; Warren, JT1

Other Studies

8 other study(ies) available for lissamine rhodamine b and Colonic Neoplasms

ArticleYear
Resveratrol modulates the topoisomerase inhibitory potential of doxorubicin in human colon carcinoma cells.
    Molecules (Basel, Switzerland), 2014, Dec-01, Volume: 19, Issue:12

    Topics: Cell Death; Cell Proliferation; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Doxorubicin; HT29 Cells; Humans; Intracellular Space; Resveratrol; Rhodamines; Stilbenes; Topoisomerase Inhibitors

2014
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
    Journal of cancer research and clinical oncology, 2009, Volume: 135, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cell Line, Tumor; Cetuximab; Colonic Neoplasms; Cyclin D1; ErbB Receptors; Fluorescent Dyes; Gene Amplification; Head and Neck Neoplasms; Humans; In Situ Hybridization, Fluorescence; Mutation; Rhodamines; Signal Transduction

2009
Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:3

    Topics: Breast Neoplasms; Colonic Neoplasms; Colony-Forming Units Assay; Colorimetry; Combined Modality Therapy; Deoxycytidine; Fluorescent Dyes; Gemcitabine; Humans; Lung Neoplasms; Radiation-Sensitizing Agents; Radiotherapy; Rhodamines; Sensitivity and Specificity; Tumor Cells, Cultured

2003
Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes.
    The Journal of pharmacy and pharmacology, 2005, Volume: 57, Issue:9

    Topics: Anacardiaceae; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Hexanes; Humans; Leukemia; Lipopolysaccharides; Macrophages, Peritoneal; Male; Medicine, Traditional; Mexico; Mice; Nitric Oxide; Plant Extracts; Prostatic Neoplasms; Rhodamines; Triterpenes; Ursolic Acid

2005
Parabolic growth patterns in 96-well plate cell growth experiments.
    In vitro cellular & developmental biology. Animal, 1999, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Cecal Neoplasms; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Ileal Neoplasms; Kinetics; Ovarian Neoplasms; Regression Analysis; Rhodamines; Sensitivity and Specificity; Staining and Labeling; Tumor Cells, Cultured

1999
In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Count; Cisplatin; Colonic Neoplasms; Drug Interactions; Drug Resistance, Neoplasm; Epirubicin; Fluorescent Dyes; Fluorouracil; Humans; Rhodamines; Tumor Cells, Cultured

2001
Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.
    British journal of cancer, 1992, Volume: 66, Issue:4

    Topics: Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Colonic Neoplasms; Drug Screening Assays, Antitumor; Feasibility Studies; Female; Head and Neck Neoplasms; Humans; Ovarian Neoplasms; Rhodamines; Tumor Cells, Cultured

1992
New colorimetric cytotoxicity assay for anticancer-drug screening.
    Journal of the National Cancer Institute, 1990, Jul-04, Volume: 82, Issue:13

    Topics: Adenocarcinoma; Calibration; Cell Count; Colonic Neoplasms; Colorimetry; Coloring Agents; Drug Screening Assays, Antitumor; Female; Humans; Hydrogen-Ion Concentration; Least-Squares Analysis; Microchemistry; Rhodamines; Trichloroacetic Acid; Tumor Cells, Cultured

1990